SIGA Technologies (SIGA) Competitors $5.39 -0.10 (-1.82%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$5.60 +0.21 (+3.80%) As of 03/3/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends SIGA vs. NAMS, WVE, EVO, SDGR, AMPH, APGE, IMCR, ARQT, KNSA, and DYNShould you be buying SIGA Technologies stock or one of its competitors? The main competitors of SIGA Technologies include NewAmsterdam Pharma (NAMS), Wave Life Sciences (WVE), Evotec (EVO), Schrödinger (SDGR), Amphastar Pharmaceuticals (AMPH), Apogee Therapeutics (APGE), Immunocore (IMCR), Arcutis Biotherapeutics (ARQT), Kiniksa Pharmaceuticals (KNSA), and Dyne Therapeutics (DYN). These companies are all part of the "pharmaceutical products" industry. SIGA Technologies vs. NewAmsterdam Pharma Wave Life Sciences Evotec Schrödinger Amphastar Pharmaceuticals Apogee Therapeutics Immunocore Arcutis Biotherapeutics Kiniksa Pharmaceuticals Dyne Therapeutics NewAmsterdam Pharma (NASDAQ:NAMS) and SIGA Technologies (NASDAQ:SIGA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, risk, earnings, dividends and media sentiment. Does the media favor NAMS or SIGA? In the previous week, NewAmsterdam Pharma had 28 more articles in the media than SIGA Technologies. MarketBeat recorded 33 mentions for NewAmsterdam Pharma and 5 mentions for SIGA Technologies. SIGA Technologies' average media sentiment score of 1.45 beat NewAmsterdam Pharma's score of 0.16 indicating that SIGA Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NewAmsterdam Pharma 5 Very Positive mention(s) 5 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SIGA Technologies 3 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in NAMS or SIGA? 89.9% of NewAmsterdam Pharma shares are owned by institutional investors. Comparatively, 55.4% of SIGA Technologies shares are owned by institutional investors. 19.5% of NewAmsterdam Pharma shares are owned by company insiders. Comparatively, 1.5% of SIGA Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts rate NAMS or SIGA? NewAmsterdam Pharma presently has a consensus price target of $43.80, indicating a potential upside of 116.08%. Given NewAmsterdam Pharma's stronger consensus rating and higher probable upside, research analysts plainly believe NewAmsterdam Pharma is more favorable than SIGA Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NewAmsterdam Pharma 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00SIGA Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, NAMS or SIGA? NewAmsterdam Pharma has a beta of -0.06, meaning that its share price is 106% less volatile than the S&P 500. Comparatively, SIGA Technologies has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500. Which has higher earnings and valuation, NAMS or SIGA? SIGA Technologies has higher revenue and earnings than NewAmsterdam Pharma. NewAmsterdam Pharma is trading at a lower price-to-earnings ratio than SIGA Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNewAmsterdam Pharma$45.56M41.10-$176.94M-$2.60-7.80SIGA Technologies$173.73M2.22$68.07M$1.204.49 Is NAMS or SIGA more profitable? SIGA Technologies has a net margin of 49.33% compared to NewAmsterdam Pharma's net margin of 0.00%. SIGA Technologies' return on equity of 49.06% beat NewAmsterdam Pharma's return on equity.Company Net Margins Return on Equity Return on Assets NewAmsterdam PharmaN/A N/A N/A SIGA Technologies 49.33%49.06%38.72% Does the MarketBeat Community believe in NAMS or SIGA? NewAmsterdam Pharma received 21 more outperform votes than SIGA Technologies when rated by MarketBeat users. Likewise, 100.00% of users gave NewAmsterdam Pharma an outperform vote while only 23.81% of users gave SIGA Technologies an outperform vote. CompanyUnderperformOutperformNewAmsterdam PharmaOutperform Votes26100.00% Underperform VotesNo VotesSIGA TechnologiesOutperform Votes523.81% Underperform Votes1676.19% SummaryNewAmsterdam Pharma and SIGA Technologies tied by winning 9 of the 18 factors compared between the two stocks. Get SIGA Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SIGA vs. The Competition Export to ExcelMetricSIGA TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$384.87M$7.21B$5.81B$8.43BDividend YieldN/A2.79%4.76%3.97%P/E Ratio4.496.1524.9419.24Price / Sales2.22187.68368.46110.22Price / Cash6.3465.6738.0534.58Price / Book1.956.447.374.28Net Income$68.07M$139.03M$3.18B$247.04M7 Day Performance-1.64%-3.52%-2.94%-3.26%1 Month Performance-7.55%-9.24%-6.84%-6.57%1 Year Performance5.89%-12.95%12.61%4.01% SIGA Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SIGASIGA Technologies2.8926 of 5 stars$5.39-1.8%N/A+3.5%$384.87M$173.73M4.4940Upcoming EarningsPositive NewsNAMSNewAmsterdam Pharma2.3134 of 5 stars$17.53-5.6%$41.60+137.3%-13.9%$1.62B$33.59M0.004Earnings ReportAnalyst RevisionWVEWave Life Sciences4.0502 of 5 stars$10.48-5.8%$22.22+112.0%+95.9%$1.60B$53.61M-9.44240EVOEvotec1.7741 of 5 stars$4.46+0.5%$5.93+33.0%-44.1%$1.58B$845.74M0.005,061Gap UpSDGRSchrödinger1.8846 of 5 stars$21.69-4.2%$32.11+48.0%-20.8%$1.58B$216.67M-9.27790Earnings ReportAnalyst RevisionAMPHAmphastar Pharmaceuticals4.372 of 5 stars$32.29+3.2%$50.33+55.9%-40.5%$1.55B$723.55M10.761,761APGEApogee Therapeutics2.9742 of 5 stars$33.37-3.4%$89.71+168.8%-15.7%$1.50BN/A-13.7991Earnings ReportAnalyst ForecastNews CoverageIMCRImmunocore1.3514 of 5 stars$29.99+0.2%$65.64+118.9%-57.2%$1.50B$249.43M-31.57320Analyst RevisionNews CoverageHigh Trading VolumeARQTArcutis Biotherapeutics3.3988 of 5 stars$12.39-4.8%$16.60+34.0%+9.0%$1.45B$59.61M-6.92150Earnings ReportAnalyst RevisionKNSAKiniksa Pharmaceuticals2.4032 of 5 stars$19.63-1.9%$36.60+86.4%-1.3%$1.42B$270.26M-140.20220Earnings ReportShort Interest ↑DYNDyne Therapeutics3.1939 of 5 stars$13.59-3.0%$49.91+267.2%-57.7%$1.38BN/A-3.82100Earnings ReportAnalyst Revision Related Companies and Tools Related Companies NewAmsterdam Pharma Alternatives Wave Life Sciences Alternatives Evotec Alternatives Schrödinger Alternatives Amphastar Pharmaceuticals Alternatives Apogee Therapeutics Alternatives Immunocore Alternatives Arcutis Biotherapeutics Alternatives Kiniksa Pharmaceuticals Alternatives Dyne Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SIGA) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredLeaked Trump video exposes his secret stocksTen investments secretly owned by Trump’s biggest backers. Ten investments intrinsically tied to the polici...Porter & Company | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SIGA Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SIGA Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
